verapamil has been researched along with Ascites in 5 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Ascites: Accumulation or retention of free fluid within the peritoneal cavity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study was designed to evaluate efficacy, toxicity, and adverse effects of combination of chemotherapy drugs and intraperitoneal perfusion of verapamil in the treatment of malignant ascites." | 9.17 | Treatment of malignant ascites with a combination of chemotherapy drugs and intraperitoneal perfusion of verapamil. ( Duan, Q; Fan, G; Fan, P; Jia, W; Liu, Y; Zhang, T; Zhu, Z, 2013) |
| "To establish a simple method for estimating residual peritoneal ascites in order to determine the optimum verapamil (VRP) initial concentration in the intraperitoneal perfusion chemotherapy." | 7.80 | Studies on assessment methods of malignant ascites residue and changes of verapamil concentration in intraperitoneal perfusion chemotherapy. ( Duan, Q; Fan, P; Jia, W; Liu, Y; Ma, K; Wen, C; Wu, Y; Zhang, T, 2014) |
| "The influence of verapamil and nifedipine on hepatic indocyanine green kinetics was studied in 12 patients with HBsAg-positive cirrhosis and ascites." | 7.67 | The influence of verapamil and nifedipine on hepatic indocyanine green clearance in patients with HBsAg-positive cirrhosis and ascites. ( Chang, TT; Chiang, BN; Kong, CW; Lay, CS; Lee, FY; Lee, SD; Lin, HC; Lo, KJ; Tsai, YT; Yang, CM, 1988) |
| "This study was designed to evaluate efficacy, toxicity, and adverse effects of combination of chemotherapy drugs and intraperitoneal perfusion of verapamil in the treatment of malignant ascites." | 5.17 | Treatment of malignant ascites with a combination of chemotherapy drugs and intraperitoneal perfusion of verapamil. ( Duan, Q; Fan, G; Fan, P; Jia, W; Liu, Y; Zhang, T; Zhu, Z, 2013) |
| "To establish a simple method for estimating residual peritoneal ascites in order to determine the optimum verapamil (VRP) initial concentration in the intraperitoneal perfusion chemotherapy." | 3.80 | Studies on assessment methods of malignant ascites residue and changes of verapamil concentration in intraperitoneal perfusion chemotherapy. ( Duan, Q; Fan, P; Jia, W; Liu, Y; Ma, K; Wen, C; Wu, Y; Zhang, T, 2014) |
| "The influence of verapamil and nifedipine on hepatic indocyanine green kinetics was studied in 12 patients with HBsAg-positive cirrhosis and ascites." | 3.67 | The influence of verapamil and nifedipine on hepatic indocyanine green clearance in patients with HBsAg-positive cirrhosis and ascites. ( Chang, TT; Chiang, BN; Kong, CW; Lay, CS; Lee, FY; Lee, SD; Lin, HC; Lo, KJ; Tsai, YT; Yang, CM, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jia, W | 2 |
| Zhu, Z | 1 |
| Zhang, T | 2 |
| Fan, G | 1 |
| Fan, P | 2 |
| Liu, Y | 2 |
| Duan, Q | 2 |
| Wen, C | 1 |
| Wu, Y | 1 |
| Ma, K | 1 |
| Yang, Y | 1 |
| Qiao, J | 1 |
| Wang, H | 1 |
| Gao, M | 1 |
| Ou, D | 1 |
| Zhang, J | 1 |
| Sun, M | 1 |
| Yang, X | 1 |
| Zhang, X | 1 |
| Guo, Y | 1 |
| Krishan, A | 1 |
| Lay, CS | 1 |
| Tsai, YT | 1 |
| Kong, CW | 1 |
| Lee, FY | 1 |
| Chang, TT | 1 |
| Lin, HC | 1 |
| Yang, CM | 1 |
| Lee, SD | 1 |
| Chiang, BN | 1 |
| Lo, KJ | 1 |
1 trial available for verapamil and Ascites
| Article | Year |
|---|---|
Treatment of malignant ascites with a combination of chemotherapy drugs and intraperitoneal perfusion of verapamil.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Disease-Free Survival; Drug Re | 2013 |
4 other studies available for verapamil and Ascites
| Article | Year |
|---|---|
Studies on assessment methods of malignant ascites residue and changes of verapamil concentration in intraperitoneal perfusion chemotherapy.
Topics: Aged; Ascites; Chromatography, Liquid; Colonic Neoplasms; Female; Humans; Infusions, Parenteral; Mal | 2014 |
Calcium antagonist verapamil prevented pulmonary arterial hypertension in broilers with ascites by arresting pulmonary vascular remodeling.
Topics: Animals; Ascites; Blood Pressure; Calcium Channel Blockers; Calcium Signaling; Chickens; Erythrocyte | 2007 |
Heterogeneity of anthracycline retention and response to efflux blockers in human tumors.
Topics: Anthracyclines; Ascites; Breast Neoplasms; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Fem | 1995 |
The influence of verapamil and nifedipine on hepatic indocyanine green clearance in patients with HBsAg-positive cirrhosis and ascites.
Topics: Aged; Ascites; Female; Hepatitis B Surface Antigens; Humans; Indocyanine Green; Liver; Liver Cirrhos | 1988 |